Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ugonna I. Ezeanya
Observed name:
U.I. Ezeanya
Institution:
NeoImmuneTech, Inc. (United States)
Observed institution:
NeoImmuneTech, Inc. (United States)
ORCID:
0000-0001-9349-8650
Observed ORCID:
0000-0001-9349-8650
OpenAlex ID:
A5043800251
Advancements of Common Gamma-Chain Family Cytokines in Cancer Immunotherapy
2022
·
Alexandra A. Wolfarth
, Swati Dhar
, et al.
·
Immune Network
·
22
The Role of Interleukin-7 in the Formation of Tertiary Lymphoid Structures and Their Prognostic Value in Gastrointestinal Cancers
2022
·
Michael Brandon Ware
, Alexandra A. Wolfarth
, et al.
·
Journal of Immunotherapy and Precision Oncology
·
21
PDF
1674P NT-I7 plus pembrolizumab combination treatment enhances infiltration of PD-1+ T cells and provides a more immunogenic tumor microenvironment: Biomarker data from the NIT-110 study
2022
·
A. Naing
, S. Ferrando-Martinez
, et al.
·
Annals of Oncology
·
2
Show more works
View as search
Works count:
3
Citation count:
45
H-index:
2
I10-index:
2
Year
Topic
Type
